EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Microplastics and nanoplastics exposure in coronary artery disease: mechanistic insights and future perspectives

Lingli Wu, Zhe Zhang, Xiangbo Shen, Peijian Shi

Frontiers in Cardiovascular Medicine · 20.11.2026 · 13

DOI: 10.3389/fcvm.2026.1951329 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 20.11.2026. Verfasst von Lingli Wu und 3 weiteren Autor:innen. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Micro- and nanoplastics (MNPs) have been detected in human cardiovascular specimens, and emerging observational evidence suggests an association between measured MNP burden and cardiovascular outcomes. This narrative review examines evidence relevant to coronary artery disease (CAD) across three distinct levels: human cardiovascular observations, experimental cardiovascular models, and mechanisms extrapolated from other systems. Proposed pathways include endothelial oxidative injury, macrophage-mediated chronic inflammation, lipid metabolic disturbance, prothrombotic effects, and dysregulated signaling pathways. We further summarize the limitations prevailing in this research field, such as the absence of unified standards for exposure quantification and particle detection, the predominance of cross-sectional clinical evidence, and unresolved questions regarding the in vivo distribution and metabolic patterns of MNPs. Future research directions are proposed covering standardized detection, in-depth exploration of molecular mechanisms, prospective cohort studies, interdisciplinary translational research, and public health prevention and control. These findings provide theoretical implications for refining CAD prevention and treatment frameworks, when considering MNPs as candidate modifiable environmental risk factors.

Zitieren

APA

Wu, L., Zhang, Z., Shen, X., & Shi, P. (2026). Microplastics and nanoplastics exposure in coronary artery disease: mechanistic insights and future perspectives. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1951329

Vancouver

Wu L, Zhang Z, Shen X, Shi P. Microplastics and nanoplastics exposure in coronary artery disease: mechanistic insights and future perspectives. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1951329

BibTeX
@article{Wu2026,
  author = {Wu, Lingli and Zhang, Zhe and Shen, Xiangbo and Shi, Peijian},
  title = {Microplastics and nanoplastics exposure in coronary artery disease: mechanistic insights and future perspectives},
  journal = {Frontiers in Cardiovascular Medicine},
  year = {2026},
  volume = {13},
  doi = {10.3389/fcvm.2026.1951329}
}
Kostenlos starten →